DUOVISC OPHTHALMIC VISCOSURGICAL DEVICE
Report
- Report Number
- 2184002-2022-00002
- Event Type
- Injury
- Date Received
- June 11, 2022
- Date of Event
- April 8, 2022
- Report Date
- July 26, 2022
- Manufacturer
- LIFECORE BIOMEDICAL, LLC
- Product Code
- LZP
- PMA / PMN Number
- P840064
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BE
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
NO LOT CODE OR SAMPLE PROVIDED. NO FURTHER EVALUATION OR ROOT CAUSE ANALYSIS CAN BE CONDUCTED AT THIS TIME. NO ROOT CAUSE COULD BE DETERMINED AS NO SAMPLE OR LOT CODE WAS PROVIDED FOR ANALYSIS. NO ACTION IS WARRANTED. THE MANUFACTURER WILL CONTINUE TO MONITOR DATA FOR EVIDENCE OF ADVERSE TRENDING AND TAKE FURTHER ACTION, AS APPROPRIATE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
BASED ON THE INFORMATION RECEIVED FOLLOWING SUBMISSION OF THE INITIAL REPORT, SUSPECT PRODUCT IS OPHTHALMIC HANDPIECE AND NOT THE OPHTHALMIC VISCOSURGICAL DEVICE FOR THE REPORTED EVENT. THE UPDATED REPORT FOR THE SUSPECTED HANDPIECE HAS BEEN SUBMITTED UNDER MFG REPORT NUM. 2028159-2022-00900. NO FURTHER REPORTS WILL BE SCHEDULED UNDER MFG REPORT NUM. 2184002-2022-00002 THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
A PHYSICIAN REPORTED THAT A PATIENT EXPERIENCED TOXIC ANTERIOR SEGMENT SYNDROME, SLIGHT PAIN, TYNDALL, CONJUNCTIVAL INFLAMMATION, AQUEOUS CELLS, CONJUNCTIVAL INFECTION WHEN AN OPHTHALMIC VISCOELASTIC WAS USED. PATIENT WAS GIVEN WITH STEROIDS, ANTIBIOTICS AND NON-STEROIDAL ANTI-INFLAMMATORY MEDICATIONS. SYMPTOMS WERE RESOLVED. NO FURTHER INFORMATION EXPECTED AS CUSTOMER WAS UNWILLING TO PROVIDE.
ADDITIONAL CORRECTED INFORMATION RECEIVED INDICATING THAT THE SUSPECT PRODUCT IS OPHTHALMIC HANDPIECE AND NOT OPHTHALMIC VISCOSURGICAL DEVICE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2821969 | DUOVISC OPHTHALMIC VISCOSURGICAL DEVICE | AID, SURGICAL, VISCOELASTIC | LZP | LIFECORE BIOMEDICAL, LLC | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Female | Required Intervention| O | ACUNEX VARIO, AN6V 20 D. |